Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Index offers a compact guide to core concepts and terms. This intro presents a snapshot of essential ideas to reference fast.
4,225 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Starting with $1,000 can spark a durable investing habit. This guide shows a simple plan to build a diversified, grow...
The Supreme Court's tariff ruling reshapes costs, consumer prices, and corporate margins. This guide breaks down the ...
The schwab u.s. dividend equity ETF surged into 2026, led by high-quality dividend growers and favorable market condi...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
As 2026 unfolds with higher volatility, analysts flag a trio of ETFs that may help retirees balance income and risk. ...
U.S. stocks rebound Tuesday after Monday’s tariff-driven drop, with the S&P 500 and Dow clawing back losses as invest...
Bitcoin moves within a volatile range as XRP and Ethereum show resilience amid evolving regulatory narratives. This c...
A leading AI-focused ETF is spreading risk across 86 stocks and delivering outsized gains, challenging the dominance ...
Merck stock jumps on a major restructuring, but Reddit sentiment shows growing skepticism as investors weigh Keytruda...
As markets swing in early 2026, three actively-managed ETFs are drawing inflows for steady income and downside protec...
When a global star resurfaces at a major awards show, money, trust, and hype collide. This piece breaks down the cont...